Engineering of Salmonella Phages into Novel Antimicrobial Tailocins

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Engineering of Salmonella Phages into Novel Antimicrobial Tailocins. / Woudstra, Cedric; Sørensen, Anders Nørgaard; Brøndsted, Lone.

In: Cells, Vol. 12, No. 22, 2637, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Woudstra, C, Sørensen, AN & Brøndsted, L 2023, 'Engineering of Salmonella Phages into Novel Antimicrobial Tailocins', Cells, vol. 12, no. 22, 2637. https://doi.org/10.3390/cells12222637

APA

Woudstra, C., Sørensen, A. N., & Brøndsted, L. (2023). Engineering of Salmonella Phages into Novel Antimicrobial Tailocins. Cells, 12(22), [2637]. https://doi.org/10.3390/cells12222637

Vancouver

Woudstra C, Sørensen AN, Brøndsted L. Engineering of Salmonella Phages into Novel Antimicrobial Tailocins. Cells. 2023;12(22). 2637. https://doi.org/10.3390/cells12222637

Author

Woudstra, Cedric ; Sørensen, Anders Nørgaard ; Brøndsted, Lone. / Engineering of Salmonella Phages into Novel Antimicrobial Tailocins. In: Cells. 2023 ; Vol. 12, No. 22.

Bibtex

@article{536d8b3c3f5e4be28f6565f1e110408f,
title = "Engineering of Salmonella Phages into Novel Antimicrobial Tailocins",
abstract = "Due to the extensive use of antibiotics, the increase of infections caused by antibiotic-resistant bacteria is now a global health concern. Phages have proven useful for treating bacterial infections and represent a promising alternative or complement to antibiotic treatment. Yet, other alternatives exist, such as bacteria-produced non-replicative protein complexes that can kill their targeted bacteria by puncturing their membrane (Tailocins). To expand the repertoire of Tailocins available, we suggest a new approach that transforms phages into Tailocins. Here, we genetically engineered the virulent Ackermannviridae phage S117, as well as temperate phages Fels-1, -2 and Gifsy-1 and -2, targeting the food pathogen Salmonella, by deleting the portal vertex or major capsid gene using CRISPR-Cas9. We report the production of Tailocin particles from engineered virulent and temperate phages able to kill their native host. Our work represents a steppingstone that taps into the huge diversity of phages and transforms them into versatile puncturing new antimicrobials.",
keywords = "Salmonella Phages/genetics, Bacteriophages/genetics, Anti-Infective Agents, Anti-Bacterial Agents/pharmacology, Salmonella, Bacteria",
author = "Cedric Woudstra and S{\o}rensen, {Anders N{\o}rgaard} and Lone Br{\o}ndsted",
year = "2023",
doi = "10.3390/cells12222637",
language = "English",
volume = "12",
journal = "Cells",
issn = "2073-4409",
publisher = "MDPI AG",
number = "22",

}

RIS

TY - JOUR

T1 - Engineering of Salmonella Phages into Novel Antimicrobial Tailocins

AU - Woudstra, Cedric

AU - Sørensen, Anders Nørgaard

AU - Brøndsted, Lone

PY - 2023

Y1 - 2023

N2 - Due to the extensive use of antibiotics, the increase of infections caused by antibiotic-resistant bacteria is now a global health concern. Phages have proven useful for treating bacterial infections and represent a promising alternative or complement to antibiotic treatment. Yet, other alternatives exist, such as bacteria-produced non-replicative protein complexes that can kill their targeted bacteria by puncturing their membrane (Tailocins). To expand the repertoire of Tailocins available, we suggest a new approach that transforms phages into Tailocins. Here, we genetically engineered the virulent Ackermannviridae phage S117, as well as temperate phages Fels-1, -2 and Gifsy-1 and -2, targeting the food pathogen Salmonella, by deleting the portal vertex or major capsid gene using CRISPR-Cas9. We report the production of Tailocin particles from engineered virulent and temperate phages able to kill their native host. Our work represents a steppingstone that taps into the huge diversity of phages and transforms them into versatile puncturing new antimicrobials.

AB - Due to the extensive use of antibiotics, the increase of infections caused by antibiotic-resistant bacteria is now a global health concern. Phages have proven useful for treating bacterial infections and represent a promising alternative or complement to antibiotic treatment. Yet, other alternatives exist, such as bacteria-produced non-replicative protein complexes that can kill their targeted bacteria by puncturing their membrane (Tailocins). To expand the repertoire of Tailocins available, we suggest a new approach that transforms phages into Tailocins. Here, we genetically engineered the virulent Ackermannviridae phage S117, as well as temperate phages Fels-1, -2 and Gifsy-1 and -2, targeting the food pathogen Salmonella, by deleting the portal vertex or major capsid gene using CRISPR-Cas9. We report the production of Tailocin particles from engineered virulent and temperate phages able to kill their native host. Our work represents a steppingstone that taps into the huge diversity of phages and transforms them into versatile puncturing new antimicrobials.

KW - Salmonella Phages/genetics

KW - Bacteriophages/genetics

KW - Anti-Infective Agents

KW - Anti-Bacterial Agents/pharmacology

KW - Salmonella

KW - Bacteria

U2 - 10.3390/cells12222637

DO - 10.3390/cells12222637

M3 - Journal article

C2 - 37998371

VL - 12

JO - Cells

JF - Cells

SN - 2073-4409

IS - 22

M1 - 2637

ER -

ID: 374523777